Sarepta Therapeutics | SRPT - EPS Earnings Per Share


Sarepta Therapeutics reported $-3.58 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.11 -3.42 May/06
FY2025Q4 Dec/2025 -3.58 -1.27 1.90 Feb/25
FY2025Q3 Sep/2025 -0.13 -0.6 0.62 Nov/03
FY2025Q2 Jun/2025 2.02 0.98 0.44 Aug/06
FY2025Q1 Mar/2025 -3.42 1.93 0.73 May/06




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Daiichi Sankyo JPY 46.79 22.27 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.53 1.38 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025